HOTCHKIS & WILEY's CLB Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 180,135 shares of Core Laboratories Inc. (CLB) worth $3.02 M, representing 0.01% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 16 quarters.
Based on 13F filings, HOTCHKIS & WILEY has maintained a strategic position in CLB, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 400,790 shares. Largest reduction occurred in Q1 2026, reducing 370,980 shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's Core Laboratories (CLB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Core Laboratories (CLB) Trades by HOTCHKIS & WILEY
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -370,980 | Reduce 67.31% | 180,135 | $16.79 |
| Q4 2025 | -8,510 | Reduce 1.52% | 551,115 | $16.03 |
| Q3 2025 | +101,755 | Add 22.22% | 559,625 | $12.36 |
| Q2 2025 | +57,080 | Add 14.24% | 457,870 | $11.52 |
| Q1 2025 | +400,790 | New Buy | 400,790 | $14.99 |
| Q3 2024 | -358,270 | Sold Out | 0 | $0.00 |
| Q2 2024 | +1,590 | Add 0.45% | 358,270 | $20.29 |
| Q1 2024 | +356,680 | New Buy | 356,680 | $17.08 |
| Q3 2022 | -170,860 | Sold Out | 0 | $0.00 |
| Q2 2022 | -18,970 | Reduce 9.99% | 170,860 | $19.81 |
| Q1 2022 | -1,370 | Reduce 0.72% | 189,830 | $31.63 |
| Q4 2021 | +117,620 | Add 159.85% | 191,200 | $22.31 |
| Q3 2021 | -16,780 | Reduce 18.57% | 73,580 | $27.75 |
| Q2 2021 | -1,260 | Reduce 1.38% | 90,360 | $38.96 |
| Q1 2021 | +22,830 | Add 33.19% | 91,620 | $28.79 |
| Q4 2020 | +68,790 | New Buy | 68,790 | $26.52 |
HOTCHKIS & WILEY's Core Laboratories Investment FAQs
HOTCHKIS & WILEY first purchased Core Laboratories Inc. (CLB) in Q4 2020, acquiring 68,790 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held Core Laboratories Inc. (CLB) for 16 quarters since Q4 2020.
HOTCHKIS & WILEY's largest addition to Core Laboratories Inc. (CLB) was in Q1 2025, adding 400,790 shares worth $6.01 M.
According to the latest 13F filing for Q1 2026, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 180,135 shares of Core Laboratories Inc. (CLB), valued at approximately $3.02 M.
As of the Q1 2026 filing, Core Laboratories Inc. (CLB) represents approximately 0.01% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.
HOTCHKIS & WILEY's peak holding in Core Laboratories Inc. (CLB) was 559,625 shares, as reported at the end of Q3 2025.